Loading...
Uxin Ltd is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown significant revenue growth in the latest quarter, its financials remain weak with negative net income and no clear technical or trading signals indicating a strong entry point. Additionally, there are no recent news catalysts or significant trading trends to support an immediate buy decision.
The MACD is slightly positive but contracting, suggesting limited momentum. RSI is neutral at 47.781, indicating no overbought or oversold conditions. Moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 3.382 with resistance at 3.668 and support at 3.095.
Revenue increased by 76.84% YoY in Q3 2025, and gross margin improved by 6.99% YoY.
Net income remains negative at -63,169,000, and EPS has shown no improvement. Stock trend analysis indicates a potential decline of up to -13.86% in the next month.
In Q3 2025, Uxin Ltd reported revenue growth of 76.84% YoY, but net income remains negative at -63,169,000. Gross margin improved to 7.5%, up 6.99% YoY, but the company still struggles with profitability.
Deutsche Bank initiated coverage with a Buy rating and a $4.50 price target, suggesting some optimism but limited immediate upside from the current price of $3.52.